- Previous Close
694.60 - Open
693.00 - Bid 683.00 x --
- Ask 690.50 x --
- Day's Range
682.00 - 694.60 - 52 Week Range
640.00 - 795.00 - Volume
3,362 - Avg. Volume
4,231 - Market Cap (intraday)
6.269B - Beta (5Y Monthly) 0.13
- PE Ratio (TTM)
8.01 - EPS (TTM)
86.19 - Earnings Date May 8, 2025 - May 12, 2025
- Forward Dividend & Yield 6.00 (0.87%)
- Ex-Dividend Date Jul 26, 2024
- 1y Target Est
--
Nitta Gelatin India Limited engages in the manufacture and sale of gelatin, ossein, dicalcium phosphate (DCP), and collagen peptides in India. It offers gelatin for pharmaceutical and edible applications; wellnex collagen peptides for collagen peptide absorption, diabetes management, bones and joints, and beauty under the Gelixer CollagenPep brand name; and DCP for use in poultry feed. The company provides chitosan for food, pharmaceutical, textile, agriculture, water treatment, and cosmetics industries, as well as ossein for agriculture and industrial applications. It exports its products to Japan, the United States, Canada, and the European Union countries. The company was formerly known as Kerala Chemicals & Proteins Limited and changed its name to Nitta Gelatin India Limited in 2008. Nitta Gelatin India Limited was incorporated in 1975 and is based in Kochi, India.
www.gelatin.in461
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: NITTAGELA.BO
View MorePerformance Overview: NITTAGELA.BO
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NITTAGELA.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NITTAGELA.BO
View MoreValuation Measures
Market Cap
6.27B
Enterprise Value
5.35B
Trailing P/E
8.01
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.17
Price/Book (mrq)
1.66
Enterprise Value/Revenue
1.00
Enterprise Value/EBITDA
4.37
Financial Highlights
Profitability and Income Statement
Profit Margin
14.44%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
5.42B
Net Income Avi to Common (ttm)
782.63M
Diluted EPS (ttm)
86.19
Balance Sheet and Cash Flow
Total Cash (mrq)
1.07B
Total Debt/Equity (mrq)
4.65%
Levered Free Cash Flow (ttm)
--